Pharming Group NV - Company Profile
Powered by
All the data and insights you need on Pharming Group NV in one report.
- Save hours of research time and resources with
our up-to-date Pharming Group NV Strategy Report
- Understand Pharming Group NV position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Pharming Group NV Marketed Drugs
Understand Pharming Group NV’s commercialized product portfolio to stay one step ahead of the market.
A sample of Pharming Group NV Marketed Drugs data
Drug Name | Generic Name | Brand Name | Company Name | Therapy Area | Indication | Development Stage | Drug Geography |
---|---|---|---|---|---|---|---|
Lorem | Lorem | Lorem | Lorem | Lorem | Lorem | Planned | Lorem |
conestat alfa | conestat alfa [INN] | Ruconest | Pharming Healthcare, Inc. | Immunology | Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) | Marketed | United States |
conestat alfa | conestat alfa [INN] | Ruconest | Hyupjin Corp | Immunology | Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) | Marketed | South Korea |
conestat alfa | conestat alfa [INN] | Ruconest | Kamada Pharmaceuticals | Immunology | Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) | Marketed | Israel |
Feature
Marketed Drugs is an integrated platform that provides interactive, comprehensive, and analytical competitive intelligence of Marketed Pharmaceutical Drug information.
Benefit
Marketed Drugs covers an extensive number of therapy areas and indications across 23 countries. Marketed Drug profiles provide a comprehensive breakdown of information spanning across Drug Details, Marketed Drug Overview (Lifecycle Management, Safety Details and Efficacy Details), Marketing Information (Regulatory Information), Clinical Trials, Sales and Consensus Forecast and Net Present Value.
Keep up-to-date on new Pipeline drug developments and market approvals. Competitive analysis of Marketed drugs.
Value
Marketed Drug data is used prominently to generate a range of premium analytical reports offering unique insight. Seamless integration makes in depth investigation of drugs extremely simple.
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward